Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice-Reference-Cited by-同舟云学术

Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice

Published:2020-03-17 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Mentoor Ilze,Nell Theo,Emjedi Zaakiyah,van Jaarsveld Paul J.,de Jager Louis,Engelbrecht Anna-Mart

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference94 articles.

1. Obesity: global epidemiology and pathogenesis;Blüher;Nat Rev Endocrinol.,2019

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin.,2018

3. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian ethnicity;Nagrani;Eur J Cancer.,2016

4. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer;Sparano;Cancer.,2012

5. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders;Choe;Front Endocrinol.,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of chemotherapy on adipose tissue remodeling: The molecular players involved in this tissue wasting;Biochimie;2024-08

2. Multimodal Phasor Approach to study breast cancer cells invasion in 3D spheroid model;2024-06-12

3. Effects of Semaglutide in Doxorubicin-Induced Cardiac Toxicity in Wistar Albino Rats;Cancer Management and Research;2024-06

4. Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response;Metabolites;2024-05-29

5. Low-Density Lipoproteins Increase Proliferation, Invasion, and Chemoresistance via an Exosome Autocrine Mechanism in MDA-MB-231 Chemoresistant Cells;Biomedicines;2024-03-27